Top

Journal of Bone and Mineral Metabolism

Published in:

01-11-2021 | Multiple Sclerosis | Original Article

Novel microbiota-related gene set enrichment analysis identified osteoporosis associated gut microbiota from autoimmune diseases

Authors: Rong-Rong Cao, Pei He, Shu-Feng Lei

Published in: Journal of Bone and Mineral Metabolism | Issue 6/2021

Abstract

Introduction

Gut microbiota is now considered to be a hidden organ that interacts bidirectionally with cellular responses in numerous organs belonged to the immune, bone, and nervous systems. Here, we aimed to investigate the relationships between gut microbiota and complex diseases by utilizing multiple publicly available genome-wide association.

Materials and methods

We applied a novel microbiota-related gene set enrichment analysis approach to detect the associations between gut microbiota and complex diseases by processing genome-wide association studies (GWASs) data sets of six autoimmune diseases (including celiac disease (CeD), inflammatory bowel diseases (IBD), multiple sclerosis (MS), primary biliary cirrhosis (PBC), type 1 diabetes (T1D) and primary sclerosing cholangitis (PSC)) and osteoporosis (OP).

Results

The family Oxalobacteraceae and genus Candidatus_Soleaferrea were found to be correlated with all of the six autoimmune diseases (FDR adjusted P < 0.05). Moreover, we observed that the six autoimmune diseases except PBC shared 3 overlapping features (including family Peptostreptococcaceae, order Gastranaerophilales and genus Romboutsia). For all of the six autoimmune diseases and BMDs (LS-BMD and TB-BMD), an association signal was observed for genus Candidatus_Soleaferrea (FDR adjusted P < 0.05). Notably, FA / FN-BMD shared the maximum number of overlapping microbial features (e.g., genus Ruminococcaceae_UCG009, Erysipelatoclostridium and Ruminococcaceae_UCG013).

Conclusion

Our study found that part of the gut microbiota could be novel regulators of BMDs and autoimmune diseases via the effects of its metabolites and may lead to a better understanding of the role played by gut microbiota in the communication of the microbiota-skeletal/immune-gut axis.

Available only for authorised users

Lerner A, Jeremias P, Matthias TJAR (2015) The World incidence and prevalence of autoimmune diseases is increasing. Int J Celiac Dis 14:479–489

Mir R, Alfardan S (2020) Osteoporosis in multiple sclerosis: the bystander effect. Multiple Sclerosis and Related Disorders 37:101604CrossRef

Liao CY, Chung CH, Chu P, Wei KY, Feng TM, Lin FH, Tsao CH, Wu CC, Chien WC (2018) Increased risk of osteoporosis in patients with primary biliary cirrhosis. PLoS ONE 13:e0194418PubMedPubMedCentralCrossRef

Schmidt T, Schwinge D, Rolvien T, Jeschke A, Schmidt C, Neven M, Butscheidt S, Kriz M, Kunzmann L, Mussawy H, Hubert J, Hawellek T, Ruther W, Oheim R, Barvencik F, Lohse AW, Schramm C, Schinke T, Amling M (2019) Th17 cell frequency is associated with low bone mass in primary sclerosing cholangitis. J Hepatol 70:941–953PubMedCrossRef

Lima CA, Lyra AC, Mendes CMC, Lopes MB, Coqueiro FG, Rocha R, Santana GO (2017) Bone mineral density and inflammatory bowel disease severity. Braz J Med Biol Res 50:e6374PubMedPubMedCentralCrossRef

Thong EP, Milat F, Enticott JC, Joham AE, Ebeling PR, Mishra GD, Teede HJ (2021) The diabetes-fracture association in women with type 1 and type 2 diabetes is partially mediated by falls: a 15-year longitudinal study. Osteoporos Int 32:1175–1184PubMedCrossRef

Walker MD, Williams J, Lewis SK, Bai JC, Lebwohl B, Green PHR (2020) Measurement of forearm bone density by dual energy X-ray absorptiometry increases the prevalence of osteoporosis in men with celiac disease. Clin Gastroenterol Hepatol 18:99–106PubMedCrossRef

Hua P, Xiong Y, Yu Z, Liu B, Zhao L (2019) Effect of chlorella pyrenoidosa protein hydrolysate-calcium chelate on calcium absorption metabolism and gut microbiota composition in low-calcium diet-fed rats. Mar Drugs 17:348PubMedCentralCrossRef

Parkar SG, Kalsbeek A, Cheeseman JF (2019) Potential role for the gut microbiota in modulating host circadian rhythms and metabolic health. Microorganisms 7:41PubMedCentralCrossRef

10.

Rettedal EA, Ilesanmi-Oyelere BL, Roy NC, Coad J, Kruger MC (2021) The gut microbiome is altered in postmenopausal women with osteoporosis and osteopenia. JBMR Plus 5:e10452PubMedPubMedCentralCrossRef

11.

Hathaway-Schrader JD, Steinkamp HM, Chavez MB, Poulides NA, Kirkpatrick JE, Chew ME, Huang E, Alekseyenko AV, Aguirre JI, Novince CM (2019) Antibiotic perturbation of gut microbiota dysregulates osteoimmune cross talk in postpubertal skeletal development. Am J Pathol 189:370–390PubMedPubMedCentralCrossRef

12.

Li JY, Chassaing B, Tyagi AM, Vaccaro C, Luo T, Adams J, Darby TM, Weitzmann MN, Mulle JG, Gewirtz AT, Jones RM, Pacifici R (2016) Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics. J Clin Invest 126:2049–2063PubMedPubMedCentralCrossRef

13.

Wang Y, Yin Y, Chen X, Zhao Y, Wu Y, Li Y, Wang X, Chen H, Xiang C (2019) Induction of intestinal Th17 cells by flagellins from segmented filamentous bacteria. Front Immunol 10:2750PubMedPubMedCentralCrossRef

14.

Schwarzer M, Makki K, Storelli G, Machuca-Gayet I, Srutkova D, Hermanova P, Martino ME, Balmand S, Hudcovic T, Heddi A, Rieusset J, Kozakova H, Vidal H, Leulier F (2016) Lactobacillus plantarum strain maintains growth of infant mice during chronic undernutrition. Science 351:854–857PubMedCrossRef

15.

Bonder MJ, Kurilshikov A, Tigchelaar EF, Mujagic Z, Imhann F et al (2016) The effect of host genetics on the gut microbiome. Nat Genet 48:1407–1412PubMedCrossRef

16.

Goodrich JK, Davenport ER, Beaumont M, Jackson MA, Knight R, Ober C, Spector TD, Bell JT, Clark AG, Ley RE (2016) Genetic Determinants of the gut microbiome in UK twins. Cell Host Microbe 19:731–743PubMedPubMedCentralCrossRef

17.

Rothschild D, Weissbrod O, Barkan E, Kurilshikov A, Korem T et al (2018) Environment dominates over host genetics in shaping human gut microbiota. Nature 555:210–215PubMedCrossRef

18.

Cheng S, Han B, Ding M, Wen Y, Ma M, Zhang L, Qi X, Cheng B, Li P, Kafle OP, Liang X, Liu L, Du Y, Zhao Y, Zhang F (2020) Identifying psychiatric disorder-associated gut microbiota using microbiota-related gene set enrichment analysis. Brief Bioinform 21:1016–1022PubMedCrossRef

19.

Dubois PC, Trynka G, Franke L, Hunt KA, Romanos J et al (2010) Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 42:295–302PubMedPubMedCentralCrossRef

20.

de Lange KM, Moutsianas L, Lee JC, Lamb CA, Luo Y et al (2017) Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat Genet 49:256–261PubMedPubMedCentralCrossRef

21.

International Multiple Sclerosis Genetics C, Wellcome Trust Case Control C, Sawcer S, Hellenthal G, Pirinen M et al (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476:214–219CrossRef

22.

Cordell HJ, Han Y, Mells GF, Li Y, Hirschfield GM et al (2015) International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways. Nat Commun 6:8019PubMedCrossRef

23.

Ji SG, Juran BD, Mucha S, Folseraas T, Jostins L et al (2017) Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease. Nat Genet 49:269–273PubMedCrossRef

24.

Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, Julier C, Morahan G, Nerup J, Nierras C, Plagnol V, Pociot F, Schuilenburg H, Smyth DJ, Stevens H, Todd JA, Walker NM, Rich SS, Type 1 Diabetes Genetics C (2009) Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 41:703–707PubMedPubMedCentralCrossRef

25.

Zheng HF, Forgetta V, Hsu YH, Estrada K, Rosello-Diez A et al (2015) Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture. Nat 526:112–117CrossRef

26.

Medina-Gomez C, Kemp JP, Trajanoska K, Luan J, Chesi A et al (2018) Life-course genome-wide association study meta-analysis of total body BMD and assessment of age-specific effects. Am J Hum Genet 102:88–102PubMedPubMedCentralCrossRef

27.

Kurilshikov A, Medina-Gomez C, Bacigalupe R, Radjabzadeh D, Wang J et al (2021) Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat Genet 53:156–165PubMedPubMedCentralCrossRef

28.

Wang K, Li M, Bucan M (2007) Pathway-based approaches for analysis of genomewide association studies. Am J Hum Genet 81:1278–1283PubMedPubMedCentralCrossRef

29.

Wen Y, Wang W, Guo X, Zhang F (2016) PAPA: a flexible tool for identifying pleiotropic pathways using genome-wide association study summaries. Bioinformatics 32:946–948PubMedCrossRef

30.

Reiner A, Yekutieli D, Benjamini Y (2003) Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 19:368–375PubMedCrossRef

31.

Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK (2019) Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 10:1523PubMedPubMedCentralCrossRef

32.

Quach D, Collins F, Parameswaran N, McCabe L, Britton RA (2018) Microbiota reconstitution does not cause bone loss in germ-free mice. mSphere 3:e00545–17PubMedPubMedCentralCrossRef

33.

Dar HY, Shukla P, Mishra PK, Anupam R, Mondal RK, Tomar GB, Sharma V, Srivastava RK (2018) Lactobacillus acidophilus inhibits bone loss and increases bone heterogeneity in osteoporotic mice via modulating Treg-Th17 cell balance. Bone Rep 8:46–56PubMedPubMedCentralCrossRef

34.

Tousen Y, Matsumoto Y, Nagahata Y, Kobayashi I, Inoue M, Ishimi Y (2019) Resistant starch attenuates bone loss in ovariectomised mice by regulating the intestinal microbiota and bone-marrow inflammation. Nutrients 11:297PubMedCentralCrossRef

35.

Cai J, Zhou L, Song X, Yin M, Liang G, Xu H, Zhang L, Jiang G, Huang F (2020) Alteration of intestinal microbiota in 3-deoxyglucosone-induced prediabetic rats. Biomed Res Int 2020:8406846PubMedPubMedCentralCrossRef

36.

Hiel S, Bindels LB, Pachikian BD, Kalala G, Broers V, Zamariola G, Chang BPI, Kambashi B, Rodriguez J, Cani PD, Neyrinck AM, Thissen JP, Luminet O, Bindelle J, Delzenne NM (2019) Effects of a diet based on inulin-rich vegetables on gut health and nutritional behavior in healthy humans. Am J Clin Nutr 109:1683–1695PubMedPubMedCentralCrossRef

37.

Liu M, Devlin JC, Hu J, Volkova A, Battaglia TW, Ho M, Asplin JR, Byrd A, Loke P, Li H, Ruggles KV, Tsirigos A, Blaser MJ, Nazzal L (2021) Microbial genetic and transcriptional contributions to oxalate degradation by the gut microbiota in health and disease. Elife 10:e63642PubMedPubMedCentralCrossRef

38.

Volkova A, Ruggles KV (2021) Predictive Metagenomic Analysis of Autoimmune Disease Identifies Robust Autoimmunity and Disease Specific Microbial Signatures. Front Microbiol 12:621310PubMedPubMedCentralCrossRef

39.

Rajilic-Stojanovic M, Shanahan F, Guarner F, de Vos WM (2013) Phylogenetic analysis of dysbiosis in ulcerative colitis during remission. Inflamm Bowel Dis 19:481–488PubMedCrossRef

40.

Lavelle A, Lennon G, O’Sullivan O, Docherty N, Balfe A, Maguire A, Mulcahy HE, Doherty G, O’Donoghue D, Hyland J, Ross RP, Coffey JC, Sheahan K, Cotter PD, Shanahan F, Winter DC, O’Connell PR (2015) Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers. Gut 64:1553–1561PubMedCrossRef

41.

Jalanka J, Cheng J, Hiippala K, Ritari J, Salojarvi J, Ruuska T, Kalliomaki M, Satokari R (2020) Colonic mucosal microbiota and association of bacterial taxa with the expression of host antimicrobial peptides in pediatric ulcerative colitis. Int J Mol Sci 21:6044PubMedCentralCrossRef

42.

Johanson DM, Goertz JE, Marin IA, Costello J, Overall CC, Gaultier A (2020) Experimental autoimmune encephalomyelitis is associated with changes of the microbiota composition in the gastrointestinal tract. Sci Rep 10:15183PubMedPubMedCentralCrossRef

43.

Russell JT, Roesch LFW, Ordberg M, Ilonen J, Atkinson MA, Schatz DA, Triplett EW, Ludvigsson J (2019) Genetic risk for autoimmunity is associated with distinct changes in the human gut microbiome. Nat Commun 10:3621PubMedPubMedCentralCrossRef

44.

Yu H, Qiu N, Meng Y, Keast R (2020) A comparative study of the modulation of the gut microbiota in rats by dietary intervention with different sources of egg-white proteins. J Sci Food Agric 100:3622–3629PubMedCrossRef

45.

Hov JR, Zhong H, Qin B, Anmarkrud JA, Holm K, Franke A, Lie BA, Karlsen TH (2015) The influence of the autoimmunity-associated ancestral HLA haplotype AH8.1 on the human gut microbiota: a cross-sectional study. PLoS ONE 10:e0133804PubMedPubMedCentralCrossRef

46.

Li R, Yao Y, Gao P, Bu S (2021) The therapeutic efficacy of curcumin vs. metformin in modulating the gut microbiota in NAFLD rats: a comparative study. Front Microbiol 11:555293PubMedPubMedCentralCrossRef

47.

Marco A, Guido F, Walter F (2015) Vitamin D and inflammatory bowel disease. Biomed Res Int 2015:470805

48.

Chen D, Li Y, Sun H, Xiao M, Zhang RL, Qiu L, Tan B, Qian JM (2020) Correlation between vitamin D status and gut microbiota in patients with inflammatory bowel disease. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 42:740–748PubMed

49.

Soo RM, Skennerton CT, Sekiguchi Y, Imelfort M, Paech SJ, Dennis PG, Steen JA, Parks DH, Tyson GW, Hugenholtz P (2014) An expanded genomic representation of the phylum cyanobacteria. Genome Biol Evol 6:1031–1045PubMedPubMedCentralCrossRef

50.

Kishikawa T, Ogawa K, Motooka D, Hosokawa A, Kinoshita M, Suzuki K, Yamamoto K, Masuda T, Matsumoto Y, Nii T, Maeda Y, Nakamura S, Inohara H, Mochizuki H, Okuno T, Okada Y (2020) A metagenome-wide association study of gut microbiome in patients with multiple sclerosis revealed novel disease pathology. Front Cell Infect Microbiol 10:585973PubMedPubMedCentralCrossRef

51.

Tremlett H, Fadrosh DW, Faruqi AA, Zhu F, Hart J, Roalstad S, Graves J, Lynch S, Waubant E, Centers U S N o P M (2016) Gut microbiota in early pediatric multiple sclerosis: a case-control study. Eur J Neurol 23:1308–1321PubMedPubMedCentralCrossRef

52.

Nam D, Mau E, Wang Y, Wright D, Silkstone D, Whetstone H, Whyne C, Alman B (2012) T-lymphocytes enable osteoblast maturation via IL-17F during the early phase of fracture repair. PLoS ONE 7:e40044PubMedPubMedCentralCrossRef

53.

Zha Z, Lv Y, Tang H, Li T, Miao Y, Cheng J, Wang G, Tan Y, Zhu Y, Xing X, Ding K, Wang Y, Yin H (2020) An orally administered butyrate-releasing xylan derivative reduces inflammation in dextran sulphate sodium-induced murine colitis. Int J Biol Macromol 156:1217–1233PubMedCrossRef

54.

Zhao X, Liu H, Wu Y, Hu N, Lei M, Zhang Y, Wang S (2020) Intervention with the crude polysaccharides of Physalis pubescens L. mitigates colitis by preventing oxidative damage, aberrant immune responses, and dysbacteriosis. J Food Sci 85:2596–2607PubMedCrossRef

55.

Tian M, Li D, Ma C, Feng Y, Hu X, Chen F (2021) Barley leaf insoluble dietary fiber alleviated dextran sulfate sodium-induced mice colitis by modulating gut microbiota. Nutrients 13:846PubMedPubMedCentralCrossRef

56.

Li JW, Fang B, Pang GF, Zhang M, Ren FZ (2019) Age- and diet-specific effects of chronic exposure to chlorpyrifos on hormones, inflammation and gut microbiota in rats. Pestic Biochem Physiol 159:68–79PubMedCrossRef

57.

Wang J, Wang Y, Gao W, Wang B, Zhao H, Zeng Y, Ji Y, Hao D (2017) Diversity analysis of gut microbiota in osteoporosis and osteopenia patients. PeerJ 5:e3450PubMedPubMedCentralCrossRef

58.

He J, Xu S, Zhang B, Xiao C, Chen Z, Si F, Fu J, Lin X, Zheng G, Yu G, Chen J (2020) Gut microbiota and metabolite alterations associated with reduced bone mineral density or bone metabolic indexes in postmenopausal osteoporosis. Aging (Albany NY) 12:8583–8604CrossRef

59.

Opstelten JL, Plassais J, van Mil SW, Achouri E, Pichaud M, Siersema PD, Oldenburg B, Cervino AC (2016) Gut microbial diversity is reduced in smokers with Crohn’s disease. Inflamm Bowel Dis 22:2070–2077PubMedCrossRef

60.

Duboc H, Rajca S, Rainteau D, Benarous D, Maubert MA et al (2013) Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut 62:531–539PubMedCrossRef

61.

Cho SW, An JH, Park H, Yang JY, Choi HJ, Kim SW, Park YJ, Kim SY, Yim M, Baek WY, Kim JE, Shin CS (2013) Positive regulation of osteogenesis by bile acid through FXR. J Bone Miner Res 28:2109–2121PubMedCrossRef

62.

Zhao YX, Song YW, Zhang L, Zheng FJ, Wang XM, Zhuang XH, Wu F, Liu J (2020) Association between bile acid metabolism and bone mineral density in postmenopausal women. Clinics (Sao Paulo) 75:e1486CrossRef

63.

Uchida S, Miyaaki H, Ichikawa T, Taura N, Miuma S, Honda T, Shibata H, Haraguchi M, Senoo T, Nakao K (2016) Risk factors for osteoporosis in patients with end-stage liver disease. Biomed Rep 5:629–633PubMedPubMedCentralCrossRef

Title: Novel microbiota-related gene set enrichment analysis identified osteoporosis associated gut microbiota from autoimmune diseases
Authors: Rong-Rong Cao
Pei He
Shu-Feng Lei
Publication date: 01-11-2021
Publisher: Springer Singapore
Keywords: Multiple Sclerosis
Chronic Inflammatory Bowel Disease
Primary Sclerosing Cholangitis
Osteoporosis
Osteoporosis
Respiratory Microbiota
Celiac Disease
Celiac Disease
Type 1 Diabetes
Published in: Journal of Bone and Mineral Metabolism / Issue 6/2021
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI: https://doi.org/10.1007/s00774-021-01247-w

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2021

Journal of Bone and Mineral Metabolism Best Paper Award 2021

Replacing sedentary time for physical activity on bone density in patients with chronic kidney disease

Efficacy of romosozumab in patients with osteoporosis on maintenance hemodialysis in Japan; an observational study

Assessment of bone repair in animal models with suppressed osteoclast function by pretreatment of bisphosphonates

Recent advances in the epigenetics of bone metabolism

Clinical performance of a novel chemiluminescent enzyme immunoassay for FGF23

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials